BIOINFRA is focused on helping win the war on cancer through cost-effective cancer screening. BIOINFRA Inc., established in 2001 at Seoul National University Cancer Research Institute has dedicated more than 15 years of research to develop an innovative in vitro cancer screening technology. In particular, under the leadership of Professor Chul-Woo Kim of Seoul National University College of Medicine, BIOINFRA developed the “Smart Cancer Screening Test”, a cancer screening test that effectively screens for cancer with only a few drops of blood. According to our proprietary research consisting of more than 20,000 cancer and non-cancer blood samples, Smart Cancer Screening Test correctly identified a meaningfully higher number of cancer and non-cancer blood samples when compare to blood-based, single tumor marker test. We are dedicated to delivering the most accurate results, providing physicians and the medical community with world-class service, and providing individuals with a convenient, cost-effective cancer screening solution.